Sunday, September 24, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
SVP, Clinical Strategy and Growth
OncoHealth
Atlanta, Georgia
Professor and Division Director of Gynecologic Oncology
Levine Cancer Institute
Atrium Health
Charlotte, North Carolina
Clinical Pharmacy Specialist
Gynecology Oncology
Division of Pharmacy
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Pharmacists - 1.25 Knowledge-based ACPE (0.125 CEUs)
This activity is intended for pharmacists, managed care pharmacists, and clinical oncology pharmacists.
The goal of this activity is for managed care and clinical pharmacists to be better able to understand patient-centered, evidence-based, and value-based care with immunotherapies in advanced endometrial cancer (EC).
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
SVP, Clinical Strategy and Growth
OncoHealth
Atlanta, Georgia
Professor and Division Director of Gynecologic Oncology
Levine Cancer Institute
Atrium Health
Charlotte, North Carolina
Clinical Pharmacy Specialist
Gynecology Oncology
Division of Pharmacy
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Medscape designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) (Universal Activity Number: JA0007105-0000-23-137-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CE Released: 4/26/2023
Valid for credit through: 4/26/2024, 11:59 PM EST
processing....
The goal of this activity is for managed care and clinical pharmacists to be better able to understand patient-centered, evidence-based, and value-based care with immunotherapies in advanced EC.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
